0A88 logo

10x Genomics LSE:0A88 Stock Report

Last Price

US$14.72

Market Cap

US$1.8b

7D

4.7%

1Y

-74.0%

Updated

25 Dec, 2024

Data

Company Financials +

10x Genomics, Inc.

LSE:0A88 Stock Report

Market Cap: US$1.8b

0A88 Stock Overview

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. More details

0A88 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Revenue is forecast to grow 5.51% per year

Trading at good value compared to peers and industry

Risk Analysis

Shareholders have been diluted in the past year

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months compared to the UK market


My Notes

Capture your thoughts, links and company narrative

10x Genomics, Inc. Competitors

Oxford Nanopore Technologies

LSE:ONT

UK£1.3b

Ergomed

AIM:ERGO

UK£701.1m

MaxCyte

AIM:MXCT

UK£345.6m

hVIVO

AIM:HVO

UK£132.7m

Price History & Performance

Summary of share price highs, lows and changes for 10x Genomics
Historical stock prices
Current Share PriceUS$14.72
52 Week HighUS$57.64
52 Week LowUS$12.94
Beta1.82
1 Month Change-1.93%
3 Month Change-32.59%
1 Year Change-73.98%
3 Year Change-89.90%
5 Year Changen/a
Change since IPO-91.24%

Recent News & Updates

Recent updates

Shareholder Returns

0A88GB Life SciencesGB Market
7D4.7%-8.9%-0.6%
1Y-74.0%-29.1%3.1%

Return vs Industry: 0A88 underperformed the UK Life Sciences industry which returned -29.1% over the past year.

Return vs Market: 0A88 underperformed the UK Market which returned 3.1% over the past year.

Price Volatility

Is 0A88's price volatile compared to industry and market?
0A88 volatility
0A88 Average Weekly Movement10.3%
Life Sciences Industry Average Movement7.5%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.6%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0A88's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: 0A88's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
20121,259Serge Saxonovwww.10xgenomics.com

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell.

10x Genomics, Inc. Fundamentals Summary

How do 10x Genomics's earnings and revenue compare to its market cap?
0A88 fundamental statistics
Market capUS$1.78b
Earnings (TTM)-US$182.55m
Revenue (TTM)US$629.74m

2.8x

P/S Ratio

-9.7x

P/E Ratio

Is 0A88 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0A88 income statement (TTM)
RevenueUS$629.74m
Cost of RevenueUS$210.13m
Gross ProfitUS$419.61m
Other ExpensesUS$602.16m
Earnings-US$182.55m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.51
Gross Margin66.63%
Net Profit Margin-28.99%
Debt/Equity Ratio0%

How did 0A88 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 20:48
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

10x Genomics, Inc. is covered by 23 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Luke SergottBarclays
Michael RyskinBofA Global Research